Skip to content
J.P. Morgan’s massive Healthcare Conference wrapped last week. BIO was busy as ever in San Francisco, connecting companies with potential partners, discussing innovation, and […]
2024 JPM Healthcare Conference: top 5 BIO takeaways Read More »
National wastewater viral activity levels for COVID-19 have been very high since December. (It wasn’t your imagination that everyone seemed sick over the holidays.)
With the new COVID surge, are we really post-pandemic? Read More »
The COVID pandemic brought the world to a standstill in 2020. Only within the last year or so have things started to get back
The next pandemic may be closer than we think, finds new study Read More »
We are one step closer to pharmacy benefit manager (PBM) reform. The U.S. House approved the Lower Costs, More Transparency Act (H.R. 5378) on
House passes Lower Costs, More Transparency Act Read More »
Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two
FDA approves CRISPR-based sickle cell treatment in historic decision Read More »
When it comes to oncology, nursing is the cornerstone of effective care. Nurses are often the health care professionals who provide the highest degree
How nurses in Africa are expanding cancer-care tool belts Read More »
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the
BIO names John F. Crowley as new President & CEO Read More »
Image: U.S. National Archives and Records Administration/Creative Commons Throughout her life, Rosalynn Carter was a true champion of public health. During her time as
Vaccinate Your Family remembers Rosalynn Carter Read More »
Clinical trial diversity has been one of the most pressing needs in the healthcare industry for decades. For this and many other reasons, the
BIO unveils updated resources to improve clinical trial diversity Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
